There is an ongoing national debate around cannabis policy. This brief position statement by the Executive Committee of the Central Drug Authorityoutlines some of the factors that have contributed to this debate, delineates reduction strategies, summarises the harms and benefits ofmarijuana, and provides recommendations. These recommendations emphasise an integrated and evidence-based approach, the need forresources to implement harm reduction strategies against continued and chronic use of alcohol and cannabis, and the potential value of afocus on decriminalisation rather than the legalisation of cannabis.
Mark S. Tremblay, Casey Gray, Shawna Babcock, Joel D. Barnes, Christa Costas Bradstreet, Dawn Carr, Guylaine Chabot, Louise Choquette, David Chorney, Cam Collyer, Susan Herrington, Katherine Janson, Ian Janssen, Richard Larouche, William Pickett, Marlene Power, Ellen Beate Hansen Sandseter, Brenda Simon, Mariana Brussoni
International Journal of Environmental Research and Public Health
Alexis Palpán Flores, Gontzal Garcı́a del Caño, Eric P. Zorrilla, S. Amoretti, Eduard Vieta, Laura Pina‐Camacho, Ana M. Sánchez-Torres, Daniel Bergé, Sergi Mas, A. González-Pinto
An-Wen Chan, Isabelle Boutron, Sally Hopewell, David Moher, Kenneth F. Schulz, Gary S. Collins, R. Tunn, Rakesh Aggarwal, Michael Berkwits, Jesse A. Berlin, Nita Bhandari, Nancy J. Butcher, Marion Campbell, Runcie C.W. Chidebe, Diana Elbourne, Andrew Farmer, Dean Fergusson, Robert Golub, Steven N. Goodman, Tammy Hoffmann, John P A Ioannidis, Brennan C Kahan, Rachel L Knowles, Sarah E Lamb, Steff Lewis, Elizabeth Loder,
Discussion(0)
No comments yet. Be the first to comment.